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ABSTRACT
Postoperative nausea and vomiting (PONV) causes distress and anxiety to the 
pediatric patient. PONV can lead to dehydration, disruption of the incision site, delayed 
discharge and cause unanticipated hospitalization after ambulatory surgery. The reported 
incidence of PONV in children can be up to twice that of the adult patient. There are 
many different strategies used in treating or preventing pediatric PONV including 
pharmacologic, nonpharmacologic, homeopathic, and multi-modal therapies. Because of 
the complex nature of PONV, it is necessary to approach its treatment with a rational 
management. The purpose of this thesis was to compare different treatment techniques 
for PONV on pediatric patients, by North Dakota certified registered nurse anesthetists 
(CRNAs). The data was then compared with the PONV low and high-risk algorithms 
created by Mott Children’s Hospital. These algorithms categorize pediatric surgical 
patients into either low-risk or high-risk candidates for PONV. The algorithms are 
evidence based and were formulated to reduce over and under use of antiemetics, promote 
cost efficiency, and to promote the appropriate use of either single dose versus multi­
modal therapy in treating pediatric PONV.
A survey was sent to all practicing CRNAs in North Dakota. The survey 
questioned North Dakota CRNAs preventative, rescue, and treatment techniques for 
pediatric PONV. The returned surveys were analyzed and compared to the Mott 
Children’s Hospital algorithms. The results of this study showed minimal variation in
IX
practice among anesthesia providers in North Dakota as compared to the evidence based 
Mott Children's Hospital algorithms. Variations were identified in the two areas of 
gender and years of experience as a practicing CRNA. When studying the 
appropriateness of treatment of pediatric PONV as compared to the Mott Children’s 
Hospital algorithm, North Dakota CRNAs were treating pediatric patients appropriately.
Data were further analyzed using chi-square to identify if a difference occurred in 
gender or years of experience when treating pediatric PONV. Analysis of the data 




In children, postoperative nausea and vomiting (PONV) remains the leading cause 
of morbidity after having surgery. Severe vomiting is associated with bleeding, 
dehydration, electrolyte imbalances, wound dehiscence, and pulmonary aspiration. Even 
mild PONV may result in a delayed hospital discharge with increased costs, as well as 
decreased parental satisfaction, and an unpleasant experience for the patient (Munro, 
2000).
Pediatric patients have twice the incidence of PONV as compared to adults. 
Factors associated with increased PONV include age, sex, history of motion sickness or 
previous PONV, surgical procedure and duration of procedure, and patient anxiety.
Infants have the lowest incidence of postoperative vomiting (POV), whereas preschool 
children have an incidence of 20%. When considering children over the age of 13 years, 
girls have a higher incidence of PONV than boys (Munro, 2000).
Unlike adults, children may not be able to describe the subjective feeling of 
nausea. The endpoint in pediatric studies is usually limited to vomiting and retching. 
Because drugs used to prevent nausea and vomiting have different effects on nausea and 
vomiting, data from adults cannot be applied to children (Thompson, 1999).
1
Significance of the Study
The ability to prevent PONV in the pediatric population requires that the 
anesthesia providers understand the psychological, physiological, and pharmacological 
causes and effects of PONV. The anesthetist must be able to identify the pediatric “at 
high-risk for PONV patient,” and to identify causative factors. PONV has been shown to 
cause increased length of stay, increased costs to the hospital and patient, and decreased 
patient satisfaction to the surgical experience. This study sought to determine whether a 
significant difference in treatment modalities amongst practicing CRNAs’ in the state of 
North Dakota exists. Upon completion of the study, the purpose of this research was to 
identify if North Dakota anesthetists are over-treating, under-treating, or appropriately 
treating pediatric PONV, as compared to the evidence-based, Mott Children’s Hospital 
algorithms.
Purpose of the Study
The purpose of this study was to compare North Dakota certified nurse 
anesthetists (CRNAs’) treatment modalities for pediatric PONV to the Mott Children’s 
Hospital algorithms for low-risk and high-risk PONV. The Mott Children’s Hospital 
algorithms were created after doing a thorough literature review. These algorithms were 
created for the management of patients with low (Appendix A) and high (Appendix B) 
risk for PONV.
Many studies have been performed comparing costs, side effects, time of dosing, 
and effectiveness of different agents. The complex nature of PONV necessitates a 
rational approach to its management. The approach should involve all phases of the 
patient’s hospital stay, with attention being paid to preoperative factors, anesthetic
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management, attention in the postoperative care unit, and discharge instruction of the 
pediatric patient. The survey evaluated how North Dakota CRNAs PONV treatment 
compared with the algorithms developed by Mott Children’s Hospital for low-risk 
(Appendix A) and high-risk patients (Appendix B).
Theoretical Framework
Nurse anesthetists with an understanding of the physiologic mechanisms involved 
with nausea and vomiting can prevent and treat PONV with the appropriate 
pharmacological agents. Nausea and vomiting are the body’s important, basic defense 
mechanisms to prevent the ingestion and absorption of toxins, as well as response to 
certain stimuli (Hansen, 1998, p. 701). Stimuli that may induce nausea and vomiting 
include olfactory, visual, vestibular, and psychogenic (Munroe, 2000). With adequate 
knowledge of pharmokinetics and triggering of nausea and vomiting, the nurse anesthetist 
can properly intervene to prevent and treat nausea and vomiting.
“Nausea is an unpleasant subjective sensation resulting from conscious 
recognition of stimulation of the vomiting centers in the medulla. Vomiting, also known 
as emesis, is the sudden, forceful expulsion of the stomach contents” (Hansen, 1998, 
p. 702). The reflex to vomit is located in the vomit center in the medulla, close to the 
fourth ventricle. The vomit center has many inputs from multiple afferent sensory 
pathways including cranial nerve X (the vagus nerve) cranial nerve VIII (the vestibular 
nerve) the limbic system, and the chemoreceptors trigger zone (Thompson, 1999). 
Stimulation of any of these areas, systems, or nerves may cause nausea and vomiting.
The vagus nerve relays sensory input from the mechanoreceptors and 
chemoreceptors in the gastrointestinal tract, the respiratory tract, and the cardiovascular
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system. The vomiting center is rich in neurotransmitters such as serotonin, dopamine, 
histamine, and acetylcholine and these neurotransmitters relay this information. The 
vestibular nerve (CN VIII) relays input from the auditory system. These receptors play a 
role in this trigger. The limbic system appears to play a role in the learned response of 
anticipated nausea and vomiting (Thompson, 1999). The blockade of these 
neurotransmitters by specific drugs has been postulated to be the mechanism-of-action of 
antiemetics.
In adult humans, nausea usually precedes vomiting, but not always. Vomiting, 
the expulsion of gastric contents, is a reflex maneuver involving both visceral and striated 
muscle. Vomiting occurs in reverse order of swallowing. The patient takes a breath 
reflexively, the upper esophageal sphincter opens, the glottis and posterior nares close, 
and the diaphragm and the abdominal muscles contract, producing emesis. Autonomic 
nervous system signs associated with nausea include excessive salivation, dilated pupils, 
tachypnea, swallowing, pallor, sweating, and tachycardia. Perioperative stimulation can 
initiate the release of central nervous system emetogenic neurochemicals, thereby 
initiating PONV (Hansen, 1998).
Persistent vomiting can result in dehydration, especially in the younger pediatric 
population. Signs of visible dehydration in the pediatric patient include dry lips and 
mouth, sunken eyes, tachypnea, tachycardia, decreased urine output, and sunken 
fontanelle. Anesthesia providers need to treat dehydration in infants and smaller children 
more aggressively. Recognizing these early or late signs of dehydration can facilitate a 
better surgical experience and a timely recovery from surgery (Thompson, 1999).
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Several patient-related factors increase pediatric POV. Patients with previous 
history of postoperative nausea and vomiting may trigger the chemoreceptor zone with 
preoperative anxiety. The chemoreceptor zone is the highly vascular area postrema on 
the surface of the brain. This area lacks a true blood brain barrier, with exposure to both 
blood and cerebral fluid, and can thus react to substances in the blood (Thompson, 1998).
Pre-operative stimuli that increase the risk of POV in the pediatric patient include 
patient-related factors such as age (greater than three years old to puberty), gender 
(female, post-puberty), hormonal balance (post-puberty patient), weight (obesity), gastric 
content (greater than 25 ml volume), prior experience of postoperative nausea and 
vomiting, history of motion sickness, and anxiety. It is essential for the anesthesia 
provider to identify the cause or origin of the nausea and vomiting (Watcha, 2004).
Research Questions
The following research questions were tested:
1. What impact does age, gender, and years of experience of North Dakota 
CRNAs have on treatment of postoperative nausea and vomiting with the 
pediatric population?
2. What are the variations in therapeutic modalities used by CRNAs’ in North 
Dakota in treatment of pediatric PONV?
3. What are the considerations that affect North Dakota CRNAs’ decision to 
treat pediatric PONV?




For the purpose of this study, the following definitions of terms were used:
Nausea: “Nausea is an uneasiness of the stomach that often accompanies the urge 
to vomit, doesn’t always lead to vomiting” (Cleveland Clinic, 2004).
Vomiting: A forcible voluntary or involuntary emptying of stomach contents 
through the mouth. The abdominal muscles tighten against a relaxed upper stomach with 
an open sphincter. The contents of the stomach are propelled up and out (Medline Plus, 
2004).
Side-effects: Side-effects of antiemetics include extrapryamidal reactions, 
hypotension, sedation, dry mouth, dysphoria, dizziness, and headache.
Low-risk: Pediatric patient at low risk for PONV has had no history of motion 
sickness, no prior surgery, and are not having a surgery with high emetogenic potential.
High-risk: Pediatric patients at high-risk for nausea and vomiting include, prior 
history of motion sickness, exposure to inhaled anesthetics (nitrous oxide), opioid 
analgesics, surgery related factors (strabismus repair, tonsillectomy, gonadal operations, 
oral or ENT procedures), and PACU-related factors (pain, vestibular imbalance, 
decreased intravascular volume, hypotension, and hypoxia).
Assumptions
The following assumptions were made for this study:
1. CRNAs completing the survey will have had sufficient pediatric experience to 
respond to the survey.
2. CRNAs will answer the survey honestly and to the best of their abilities.
3. CRNAs will understand the questions, and answer the survey completely.
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Limitations
The following limitations were identified for this study:
1. CRNAs that responded to the survey may have had limited exposure to 
pediatric patients.
2. The survey is limited to North Dakota CRNAs and the data may not be 
transferable to other populations.
3. CRNAs are performing sufficient follow-up to identify whether or not patients 
are experiencing PONV.
4. The responses of the non-respondents could have been greatly different from 
those responses actually received.
5. Nausea is a subjective experience, which may not be reported or identifiable 
by the pediatric patient, making it difficult for the CRNA to assess.
6. Controlling for extenuating circumstances is difficult in the operative setting, 




Postoperative nausea and vomiting has been extensively studied in the adult 
population. Unlike the adult population, the pediatric population has not received the 
extensive evaluation of PONV. Since pediatric PONV continues to be the leading cause 
of morbidity postoperatively, this area warrants further discussion and literature review.
Approaches to the treatment and prevention of PONV are numerous. Initially, the 
anesthetist must be aware of preoperative, intraoperative, and postoperative factors that 
can contribute to PONV for each individual patient. The financial implication of 
treatment of PONV has always been a concern for hospitals. Many studies have been 
done with regard to identifying the patient that warrants treatment and the drug(s) that 
is/are effective. In addition, pharmacologic, nonpharmologic, and multi-modal 
approaches to treatment and prevention of postoperative nausea and vomiting have been 
extensively reviewed and studied. The review of literature focuses on the pediatric 
population in regards to PONV.
Operative Factors
To identify whether or not a correlation existed, Wang and Kain (2000) studied 
preoperative anxiety and PONV. Anxiety was assessed in the preoperative holding area 
and upon induction of anesthesia. The researchers used a self-reporting behavioral 
instrument to assess and score patient anxiety. They found that controlling for
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confounding variables, such as anxiety in the preoperative holding area, did not have any 
predictive value for the occurrence of PONV.
Intra-operative factors that have been identified as risk factors for postoperative 
nausea and vomiting include type of surgery, duration of surgery, and type of anesthesia. 
Surgeries associated with high incidence of nausea and vomiting are adenotonsillectomy, 
dental extraction, herniorrhaphy, orchiopexy, middle ear, and ophthalmic procedures 
(Watcha, 2004). Children frequently have surgeries in these areas. “The longer the 
duration of the operation and the longer the time for anesthesia, the risk increase for 
nausea and vomiting” (Gan et al., 2003). Due to increased time to clear anesthesia from 
the patients’ system, the risk of developing postoperative nausea and vomiting is 
increased with longer anesthesia time.
The type of anesthesia used is also associated with increased risk. General 
anesthesia has a higher risk than total intravenous anesthesia, or regional anesthesia. 
Certain intravenous medications that are commonly used for induction of anesthesia have 
been identified as causing PONV, such as opioids, etomidate, and ketamine. Newer 
agents such as Propofol® seem to exert an anti-emetic effect. Research on the inhalation 
anesthetic agent nitrous oxide is inconclusive (Drake et al., 2001).
Postoperative factors that affect nausea and vomiting include pain, hypotension, 
oral intake, movement, and opioid analgesia. Pain is a known factor in postoperative 
nausea and vomiting. With the relief of pain, patients usually have the sensation of 
nausea subside. Hypotension from sympathetic blockade, fluid restriction, blood loss, or 
anesthetics have been shown to induce nausea. The restriction of oral intake until the 
return of bowel function has also been shown to delay, and possibly to decrease, the
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incidence of postoperative nausea and vomiting. The use of opioid analgesics increases 
postoperative nausea and vomiting, but the use of ketorolac, a nonsteroidal anti­
inflammatory, has been proven to decrease the affect of PONV (Rose & Watcha, 1999).
Cost
Despite advances in pharmacology, PONV continues to be a common occurrence, 
which incurs large hospital costs. Studies evaluating the pharmaco-economics of 
antiemetics used for the prevention and treatment of POV in children are limited. Older 
antiemetics, such as anticholinergics and dopamine-receptor antagonists, are less 
expensive than newer agents such as serotonin (5-HT3) receptor antagonists (Watcha, 
2004).
Determination of the costs of an anti emetic regimen should include: drug 
acquisition cost, pharmacy supply cost, and costs associated with managing therapy 
failure (i.e., additional treatment costs, such as costs of resources for emesis cleanup, 
labor costs, and lost caregiver income because of a patient’s prolonged illness). Only a 
few analyses studies have been done using these cost indicators (Watcha, 2004).
Olutoye, Jantzen, Alexis, Rajechert, Shreiner, & Watcha studied the cost 
effectiveness of two 5-HT3 blockers, granisetron and ondansetron. Thee study had two 
goals, to find the smallest, effective dose of granisetron, and to compare costs of 
managing POV dolasetron to treatment with ondansetron. The smallest, effective dose 
for granisetron was 350 mcq/kg, which was more cost-effective than the use of 
ondansetron. The study showed that prophylactic treatment with either drug was equal, 
but granisetron was more cost-effective than ondansetron. “Since it is difficult to assess 
patient satisfaction in the pediatric population, the outcome of cost-effectiveness must be
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must be weighed against what common sense tells the provider in doing the right thing 
for the pediatric patient” (Olutoye, 2003).
Carroll et al. (1999) noted that in the outpatient surgical center, the average cost 
of treating a patient for prevention of PONV was $14.94. The estimated per-patient 
treatment cost to surgical centers for patients who experienced PONV was $415. This 
cost reflects personnel wages, supplies and drugs, increased length of stay in the post 
anesthesia unit, and the backlog created on the operating room schedule. In addition to 
the increased cost of postoperative nausea and vomiting, the pediatric patient may 
develop life-long fears and dissatisfaction with the surgical experience. Some adult 
patients have stated that the postoperative nausea and vomiting was more disabling than 
the operation itself (Thompson, 1998).
Pharmacologic
Known as antiemetics, pharmacologic agents work by blocking the receptors 
involved in the process of vomiting. The four receptors that are blocked by 
chemoreceptor trigger zone drugs include serotonin, dopamine, cholinergic, and 
histamine. Drugs that block these receptors are called serotonin type 3 (5-HT3) receptor 
blockers, anticholinergics, antihistamines, and dopamine receptor blockers. Many studies 
have been performed on antiemetic drugs to evaluate both their effectiveness and side- 
effects. Depending on the dosage of the drug used, the side effects can increase or 
decrease. Common side-effects include extrapyramidal reactions, hypotension, sedation, 
dry mouth, dysphoria, dizziness, and headache (Gan, Meyer, Apfel, Chung, Davis, 
Eubanks, Kovac, Philip, Sessler, Temo, Tramer, & Watcha, 2003). Extrapyramidal 
reactions are identified as symptoms that resemble parkinsonian syndrome. These
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symptoms are characterized by restlessness, oculogyries, bradykinesia, muscle rigidity, 
akathisia, and acute dystonic reactions (Hansen, 1998).
“The ideal antiemetic would be effective, free of side effects, and inexpensive” 
(Gan, 2003). Nurse anesthetists must be aware of the latest research regarding antiemetic 
therapy and PONV. For prevention and treatment of PONV, pharmacologic studies have 
been done comparing drug dose, drug effectiveness, cost, and timing of the dose 
administration. Many of the studies were specific to certain high-risk surgeries for the 
pediatric patient.
Serotonin Receptor Antagonists
Serotonin (5-HT3) receptor antagonists such as ondansetron, granisetron, and 
dolasetron produce antiemetic activity by selectively inhibiting 5-HT3 receptors located 
in both the central and peripheral nervous system. Because they are effective and 
relatively free of side-effects and sedation, the development of these drugs are considered 
a major advancement in pediatric POV. The most common reported side-effect was 
headache and dizziness. Because 5-HT3 receptor antagonists are more effective in 
preventing vomiting than preventing nausea, these drugs are considered to be the drugs- 
of-choice for treating prophylaxis of POV in children (Munroe, 2000).
Patel, Davis, Orr, Ferrari, Rimar, Hannallah, Cohen, Colingo, Donlon, Haberkern, 
McGowan, Prillaman, Parasuraman, and Creed (1997) studied the use of single-dose 
ondansetron (Zofran®) for prevention of PONV in pediatric outpatient. The study 
evaluated the safety and efficacy of ondansetron compared to placebo in prevention of 
PONV. This study concluded that ondansetron effectively prevented PONV in pediatric 
patients undergoing outpatient surgical procedures associated with high risk
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postoperative vomiting. In addition, prophylactic use of ondansetron was found to reduce 
the time to reach criteria for home readiness and time to discharge from the facility.
Watcha, Bras, Cieslak, and Pennant (1995) studied the dose response relationship 
of the antiemetic ondansetron in preventing postoperative emesis in pediatric patients 
undergoing ambulatory surgery. Before this study, dosing had been based on 
chemotherapy-induced emesis, which was 100-150 mcq/kg. The study concluded that a 
dose of 50 mcg/kg was as effective as a larger dose of lOOmcq/kg. Using the smaller 
dose showed decreased side-effects from the antiemetic such as extrapryamidal reactions. 
Since ondansetron is the most expensive antiemetic currently on the market, this smaller 
dosing is significant in that it may be more cost-effective to both the patient and the 
hospital, if multi-dose vials are used.
Sadhasivam, Shende, and Madan (2000) studied the prophylactic use of 
ondansetron in prevention of PONV following pediatric strabismus surgery. In children, 
strabismus repair is associated with the highest incidence of PONV -  as many as 88% of 
patients that do not receive antiemetics will experience PONV. The researchers stated 
that patient comfort or satisfaction is one of the most important true outcome measures of 
surgery. With total elimination of PONV, any improvement in patient satisfaction with 
prophylactic antiemetics is a worthwhile treatment. Because of its benefits in terms of 
effectiveness and safety, the researchers felt that cost containment should not be an issue 
when treating the pediatric patient. Until a safer, better, and more cost-effective 
alternative is available, this study concluded that routine, prophylactic treatment with 
ondansetron is justified.
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Cieslak, Watcha, Phillips, and Pennant (1996) studied the dose-response relation 
and cost-effectiveness of granisetron for the prophylaxis of pediatric PONV. In a 
randomized, double-blind, placebo-controlled study, 97 pediatric outpatients received a 
10 to 40 meg intravenous dose of placebo or granisetron during standardized anesthetic. 
Granisetron provided effective prophylaxis in children against PONV, but only with the 
larger dose. Granisetron was shown to reduce significantly the incidence of PONV when 
administered at higher doses. Granisetron has a prolonged duration of action with a 
single dose, so patients who received this drug had decreased emesis for the 24-hour 
period post anesthetic, which also offset cost of therapy. The dose required to treat 
PONV was higher than the Food and Drug Administration recommended dose for 
emesis. The researchers reported that further studies needed to be conducted that would 
include cost, patient satisfaction and preferences, in addition to efficacy.
Dopamine Receptor Antagonists
Dopamine receptor antagonists that are effective in preventing and treating 
pediatric POV include the benzamides (metoclopramide), butyrophenones (droperidol), 
and phenothiazines (promethazine and perphenazine). Each of these agents exerts an 
antiemetic effect, primarily by blocking dopamine receptors in the chemo-trigger zone 
(Kovac, 2000).
Droperidol has proven efficacy in the prevention and treatment of POV in 
children. Recent reports of electrocardiogram rhythm changes with the use of droperidol 
led the FDA to insert a black box warning in the package insert. The initial report was 
based on the usage of large doses (>25 mg) for management of manic depressant patients.
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The warning emphasized that the use of benzodiazepines, volatile anesthetics, and 
opioids increases the risk of prolonged QT syndrome (White, 2002).
Granisetron-droperidol drug combination to prevent PONV in children was 
studied by Fujii, Tanaka, and Toyooka (1999). Since droperidol is a dopamine receptor 
blocker, and granisetron, like ondansetron, is a serotonin (5-HT3) receptor blocker (also 
known as antiserotonin agents), they have differing side-effects. Droperidol is associated 
with the side-effects of excessive sedation, hypotension, dry mouth, dysphoria, 
restlessness, and extrapryamidal symptoms. The new agents of 5-HT3 blockers are more 
expensive, but have very few side-effects. Granisetron is the only new oral agent of 5- 
HT3 blockers available. The researchers found the combination to be more effective than 
single drug therapy for PONV, covering two different areas in the vomiting center.
Although phenothiazines are primarily CNS dopamine-receptor antagonists, they 
also have modest anticholinergic and anti-histiminergic effects. These drugs are effective 
in preventing and treating POV by countering the effects of drugs that stimulate the 
chemo-trigger zone. Adverse effects of phenothiazines include extrapyramidal effects 
and sedation (Kovac, 2000). These adverse affects may complicate postoperative care, or 
prolong hospitalization, limiting their use in POV prophylaxis (Rose, 1999).
Fujii, Toyooka, and Tanaka (1998) compared oral granisetron to phenothiazine 
for the reduction of PONV after tonsillectomies in children. One hundred and eighty 
pediatric patients, aged 4 to 10 years, were enrolled in a prospective, randomized, double­
blind investigation, and assigned to one of three treatment regimens: granisetron, 
compazine, or granisetron plus compazine. Noting that the cost difference between 
granisetron and compazine may be a factor for hospital choice of antemetic drugs, the
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researchers concluded that preoperative oral granisetron was more effective than 
compazine. As of this writing, oral granisetron is $12.60 per dose, and oral compazine is 
$0.90 per dose; therefore, using granisetron may be considered cost prohibitive.
Anticholinergic Agents
Anticholinergic agents are potent inhibitors of cholinergic and muscurinic 
receptors located in the nucleus of the solitary tract and vestibular apparatus. Adverse 
affects of anticholinergic agents is dry mouth, visual disturbances, sedation, dysphoria, 
and hallucinations (Kovac, 2000). The typical anticholinergics used in the pediatric 
population are atropine and glycopyrrolate.
Neuromuscular blockade, which is often required in surgery, is reversed with 
anticholinestrases, such as neostigmine or edrophoneum. Neostigmine must be given in 
combination with the anticholinergics, such as atropine or glycopyrrolate, to prevent 
severe bradycardia or sinus arrest. Chibber, Lustik, Thakur, Francisco, and Fickling 
(1999) studied the effects of anticholinergics on PONV, recovery, and hospital stay in 
children undergoing tonsillectomy with or without adenoidectomy. The researchers 
found that in children undergoing tonsillectomy, reversal of neuromuscular blockade with 
atropine and neostigmine is associated with a lesser incidence of PONV, compared with 
glycopyrrolate and neostigmine.
Antihistamine Agents
Antihistamines block histamine receptors in the nucleus of the solitary tract and 
acetylcholine in the vestibular apparatus (Kovac, 2000). These drugs may be effective in 
preventing or controlling emesis following vestibular stimulation, which occurs during 
middle ear surgery and postoperative motion sickness, but their overall weak antiemetic
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properties and the profound sedation caused by antiemetics make these drugs less suitable 
for the management of POV. The consensus guidelines for management of POV does 
not recommend the use of antihistamines in the treatment of PONV (Gan, 2003).
Steroids
Cortical steroids exert antiemetic properties by a mechanism that is yet unknown. 
Proposed mechanisms include prostaglandin antagonism, endorphin release, reduction in 
serotonin levels in the brain and gastrointestinal tract, anti-inflammatory, and membrane- 
stabilization effects (Watcha, 2004). Studies have been conducted either with steroids 
given alone, or in combination with other antiemetics.
Aouad, Siddik, Rizk, Zaytoun, and Baraka (2001) studied the effect of 
dexamethasone, a corticosteroid, on post-tonsillectomy PONV. This study compared 
early and late vomiting, time to first oral intake, quality of oral intake, satisfaction scores, 
and duration of IV hydration. The overall incidence of vomiting, as well as the incidence 
of late vomiting, was significantly less after the administration of dexamethasone. The 
time to first oral intake and the duration of IV hydration were shorter after 
dexamethasone was given. Due to this procedures high risk for PONV, the researchers 
recommended dexamethasone be given to pediatric patients prior to tonsillectomy 
surgery.
Children undergoing tonsillectomies are at particular risk because of the location 
of the surgical site, and increased incidence of swallowing blood and secretions. Splinter 
and Roberts (1997) conducted a study comparing two drugs, dexamethasone and 
promethazine, for vomiting after tonsillectomy. The researchers chose these two drugs to 
study because they are relatively inexpensive antiemetics that decrease vomiting after
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tonsillectomies. When analyzing the data, the researchers noted that there was an 
increase in POV when inhaled anesthetics were used over total IV induction with 
propofol. Propofol is an induction agent used by anesthesia that acts by mimicking 
GABA action. Other actions include a rapid, pleasant recovery, and antiemetic effects. 
More female patients were found to have complications of POV than males. Further 
investigation was suggested to determine whether this was a spurious result of genuine 
observation. They found that droperidol was more effective than dexamethasone before 
discharge from the hospital but that the two drugs had similar effects after discharge.
Nonpharmacologic
Nonpharmacologic drugs for PONV can be used effectively as preventative 
measures. Nonpharmacologic treatments that have shown effectiveness in prevention of 
PONV are acupuncture, electroacupuncture, and hypnosis. Acupuncture, a Chinese form 
of medicine, is thought to prevent nausea and vomiting, but the mechanism is not clear.
Its effectiveness may be related to release of endorphins, adjustment of autonomic nerves, 
and improvement in motility of the intestines and stomach. The P6 acupressure point, 
used by acupuncturists, is located in an area on the forearm that with application of 
pressure has been found to be effective for prevention of motion sickness and PONV. 
These methods of reducing PONV in the pediatric population have not received a lot of 
study (Gan et al., 2003).
In 2002, Rusy, Hoffman, and Weisman conducted a study using 
electroacupuncture for prophylaxis of PONV following pediatric tonsillectomy. The 
researchers found that this nonpharmacologic method did reduce PONV in the awake 
pediatric patient that received acupuncture, but did not reduce the incidence of PONV
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when used as a rescue antiemetic. This study also questioned the appropriateness of 
using this method for the pediatric population.
The ability to tolerate fluids is a common criterion for discharge from day 
surgery; however, requiring children to drink oral fluids is also thought to exacerbate 
PONV. Kearney, Mack, and Entwistle (1998) withheld oral fluids from children who had 
undergone outpatient surgery to study the affect of PONV. The researchers found that 
withholding oral fluid was well tolerated, inexpensive, did not contribute to increased 
hospital stay or unanticipated admission, and markedly decreased vomiting in patients 
requiring opioids perioperatively. The practice of requiring pediatric patients to take oral 
intake prior to discharge was removed from the discharge criterion at the researchers’ 
facility at the conclusion of the study.
Multimodal/Combination Therapy
Because several neurochemicals receptors are involved in the pathogenesis of 
emesis, using a combination regimen for preventing POV is a rational approach.
Many practitioners are using a multi-modal PONV management protocol. Simple 
techniques such as >80% inspired oxygen, adequate intravenous fluids, avoiding nitrous 
oxide and neuromuscular blocking agent, and propofol should be used. The surgeon may 
perform a procedure in which local anesthesia is infiltrated over the surgical site. This 
procedure improves pain management, which decreases PONV. In addition, giving 
ketorolac at the end of surgery has been proven effective in decreasing PONV by 
minimizing postoperative pain (Scuderi et al., 1999).
Gan et al. (2003) studied the multimodal approach that was the closest to 
eliminating nausea and vomiting postoperatively. They stated that a multimodal
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approach to treatment of PONV should be used when high-risk patients are identified. 
Emetogenic stimuli, such as pain, motion, or a noisy environment should be avoided or 
reduced. Therapy may include anxiolytics (benzodiazepines such as Versed), adequate 
IV hydration, withholding of oral fluids, prophylactic antiemetics (consider combination 
therapy), total IV anesthesia (with Propofol), effective anesthesia with local anesthesia, 
nonsteroidal anti-inflammatory drugs (with ketorolac), supplemental oxygen, and 
nonpharmacologic techniques such as acupuncture, electro-acupuncture, hypnosis.
Drake, Anderson, Persson, and Thompson (2001) studied the impact of an 
antiemetic protocol on PONV in children. The researchers introduced an antiemetic 
protocol aimed for PONV management in which 272 children were enrolled in the study: 
138 in Group 1, and 134 in Group 2. There was a difference between the two groups for 
gender, type of surgery, perioperative opioid, and perioperative antiemetic use. The 
protocol aimed to rationalize prescribing based on cost, with the least expensive drug 
being used. The study showed that the introduction of an antiemetic protocol for 
symptomatic management of PONV made a positive result impact on the severity of 
symptoms.
Because many studies have had contradictory conclusions concerning one 
effective regimen, not all research on pediatric PONV has been in agreement on an exact 
treatment protocol. The medical staff at Mott Children’s Hospital created two algorithms 
for treating low- and high-risk pediatric PONV that have been found to be effective: 
these researchers found that routine prophylaxis for all surgical patients was not 
necessarily indicated. If a pediatric patient is considered low-risk (Appendix A), 
traditional antiemetics such as droperidol for treatment of PONV and ondansetron for
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rescue should be used; however, those children in the high-risk group (Appendix B) who 
had a previous history of PONV, motion sickness, strabismus or tonsillectomy surgery, 
should be treated with a more cautious approach.
A rational plan for a child in a high-risk group should include the intake of fluids 
up to two hours preoperatively, a benzodiazepine premedication, and the use of a regional 
technique when appropriate. If general anesthesia is necessary, consider using propofol 
and/or total intravenous anesthetic, use sevoflurane as the inhaled agent, if needed, 
avoiding nitrous oxide, and opioid. The use of nonsteroidal anti-inflammatory agents 
when possible, and other local anesthetic wound infiltration or regional nerve blocks was 
preferred. Combination antiemetics should be administered prophylactically (i.e. 
ondansetron, droperidol, and/or dexamethasone) (Munro, 2000).
A cost-analysis has shown that the more expensive drug, ondansetron, is only 
cost-effective if the frequency of emesis exceeded 33%, whereas prophylactic droperidol 
is cost-effective if the frequency of emesis is 10%. If prophylactic antiemetic medication 
fails, a drug from a different class should be administered. In addition, the treatment of 
established PONV is more difficult, especially if it occurs after hospital discharge. It is 
important to treat pain and dehydration, and to avoid other precipitating factors such as 
oral intake, movement, etc. In the event that all of these interventions fail, hospital 
admission may be necessary (Munro, 2000).
Postoperatively, patients should emerge from anesthesia in a quiet environment, 
well-hydrated, and free of pain. In addition, patients should avoid early oral intake and 
movement; should PONV occur, a drug from a different class that has not already been 
used should be prescribed. Given a rational approach to the management of PONV,
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reducing the unpleasant side-effects of anesthesia to low levels in children undergoing 
surgery should be possible (Munro, 2003).
Summary of Literature Review
A multitude of studies have been performed comparing different drugs from 
similar pharmacologic classes and other pharmacologic classes. More recent research has 
focused on a multimodal technique. The focus has turned to not only treating PONV but 
also preventing PONV prior to the occurrence. The research includes identifying 
pediatric patients at risk, treatment preoperative, and avoiding triggering factors. This 
rational approach to pediatric PONV was used in studying North Dakota CRNAs’ 
treatment of pediatric PONV.
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CHAPTER III
METHODOLOGY OF THE STUDY 
Introduction
Chapter III presents the methodology of this quantitative, comparative study. The 
study was conducted using a survey sent out to all North Dakota Certified Registered 
Nurse Anesthetist. The following research questions were answered in this chapter.
The research questions that were answered include:
1. What impact does age, gender, and years of experience of North Dakota 
CRNAs have on treatment of postoperative nausea and vomiting in the 
pediatric population?
2. What are the therapeutic modalities used by CRNAs in North Dakota to 
treating pediatric PONV?
3. What are the considerations that affect CRNA’s decision on how to treat 
pediatric PONV?
4. Will the treatment modalities for CRNAs in North Dakota with regards to 
treating pediatric PONV be similar to the Mott Children’s Hospital 
algorithms?
The population, sample, study design, data collection, instrument reliability and 
validity, and protection of human subjects are presented.
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Population and Sample
The population and sample for this study consisted of practicing North Dakota 
certified registered nurse anesthetists. A list of the CRNA’s of North Dakota was 
obtained from the North Dakota Board of Nursing. A survey asked specific questions 
pertaining to prevention, treatment, and rescue practices for pediatric postoperative 
nausea and vomiting. The results of the study were specific to pediatric population. All 
participants received the same survey.
The surgical procedures specifically identified were tonsillectomy, middle ear, 
strabismus, abdominal, inguinal hernia, and orthopedic. In this study, the survey 
documented North Dakota CRNA’s treatment modalities, and the efficiency of treatment 
options. The results were then compared to the Mott Children's Hospital algorithms for 
treatment of low-risk and high-risk pediatric patients for PONV. The medical staff at 
Mott Children’s Hospital created two algorithms for treating low and high risk pediatric 
PONV that have been found to he effective. Treatment for all pediatric patients was not 
necessary. The indication for treatment was identified for patients that fall into either 
low- or high-risk categories. If a pediatric patient is considered low-risk (Appendix A), 
then traditional antiemetics such as droperidol for treatment of PONV and ondansetron 
for rescue should be used. However, those children in the high-risk group (Appendix B) 
such as previous history of PONV, motion sickness, strabismus or tonsillectomy surgery, 
should be treated with a more cautious approach.
Study Design
The study was a non-experimental, exploratory, descriptive survey. The data 
were obtained from North Dakota CRNAs regarding their practice of treating and
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preventing pediatric PONV. Information was collected to compare the North Dakota 
CRNAs practice to Mott Children’s Hospital algorithms for treating pediatric PONV. To 
analyze the treatment options of the North Dakota anesthetists, a questionnaire was 
created by the researcher. The relationship to the Mott Children’s Hospital algorithms 
was explored to determine whether or not differences in practice techniques exist. The 
same investigator reviewed all questionnaires that were returned.
Data Collection Method
North Dakota nurse anesthetists were sent a survey and cover letter informing 
them of the intentions of this researcher. These anesthetists were mailed this survey with 
a stamped return envelope to maintain anonymity. The data collection period was from 
when the survey was sent out in September 20, 2004, to November 30, 2004. In the 
cover letter (Appendix E), the participants were informed of the purpose and procedure of 
the study. In the survey (Appendix F), the participants were asked their years of 
experience, gender, frequency of working with pediatric patients, status of employment, 
use of prophylactic antiemetics, incidence of PONV after anesthesia, medications 
administered to avoid PONV, surgeries that were routinely treated for PONV, and 
effectiveness of medications that were used. One advantage of using a questionnaire 
included the ability to elicit attitudes, beliefs, and opinions; a second advantage included 
incorporation of a large sample size. Lastly, less bias is reported when comparing 
questionnaires with interviews.
Instrument Reliability and Validity
The best tool limits error in measurement. In order to maximize reliability and 
validity of the survey tool, a pilot-group, an anesthesia instructor, and the chairperson of
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the researcher’s thesis committee were used to evaluate the questionnaire. The pilot- 
group used for this purpose consisted of an anesthesia professor, a doctoral professor of 
research nursing, and eleven first-year anesthesia students -  all from the University of 
North Dakota. Recommendations were taken into account to improve the survey and 
revisions were made in conjunction with the group’s input. The data obtained from the 
pilot group were not included in the survey results.
Data Analysis
Data analysis was completed to address the research questions of the study. The 
analysis for this study involved descriptive analysis of the data gathered through the 
survey tool. A coding guide was developed for data entry. Each survey was numbered 
and data was analyzed. Statistical Package for the Social Sciences (SPSS®) and an 
Excel® spreadsheet were used to provide statistical results. Since data were collected 
from one population, chi-square and ANOVA were used to compare the significance in 
nominal variables of gender, years of experience, status of employment (full-time, part- 
time, and locum), and factors affecting decision to treat pediatric PONV. For the entire 
study, the level of statistical significance (p-value) was set at 0.05. A two-tailed test was 
used to test for statistical significance in ratio variables.
Protection of Human Subjects
Institutional Review Board (IRB) approval was obtained from the University of 
North Dakota. The subjects involved in this study were not asked to identify themselves. 
This data collected will be locked and stored in the nursing building on the University of 
North Dakota campus in a locked cabinet for three years, and after that time, the 
information will be destroyed. In order to obtain additional information in regard to this
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study (if they so desired), the participants were given the researcher’s name and address, 
the researcher’s advisor, Dr. Julie Anderson's name and telephone number, as well as the 
University of North Dakota’s Institutional Research Board telephone number. The cover 
letter (Appendix E) containing this information served as the consent for the study. A 
stamped, self-addressed envelope was sent with each survey. There was no identified 
risk to the subjects of the study; data was reported in aggregated format.
The benefits of participating in the study include the participants’ reflection of 
their own practice, which may lead to a more beneficial behavior in anesthesia care. This 




Nurse anesthetists with an understanding of the physiologic mechanisms involved 
with nausea and vomiting can prevent and treat PONV with the appropriate 
pharmacological agents. With adequate knowledge of pharmokinetics and triggering of 
nausea and vomiting, the nurse anesthetist can properly intervene to prevent and treat 
nausea and vomiting.
The vomiting center is rich in neurotransmitters such as serotonin, dopamine, 
histamine, and acetylcholine and these neurotransmitters relay this information. These 
receptors play a role in this trigger (Thompson, 1999). The blockade of these 
neurotransmitters by specific drugs has been postulated to be the mechanism-of-action of 
antiemetics. With the use of this physiologic framework, CRNAs can better treat 
pediatric PONV.
The purpose of this study was to evaluate North Dakota CRNAs treatment of 
pediatric postoperative nausea and vomiting. Since pediatric postoperative nausea and 
vomiting continues to be the leading cause of morbidity postoperatively, CRNAs need to 
be aware of low and high risks for pediatric PONV. Mott Children’s Hospital algorithms 
have a rational approach to the treatment of PONV. The surveys of North Dakota 
CRNAs were compared against the Mott Children’s Hospital algorithms.
The following research questions addressed in this study:
28
1. What impact does age, gender, and years of experience of North Dakota 
CRNAs have on treatment of postoperative nausea and vomiting in the 
pediatric population?
2. What are the variations in therapeutic modalities used by CRNAs’ in North 
Dakota in treatment of pediatric PONV?
3. What are the considerations that affect North Dakota CRNAs’ decision to 
treat pediatric PONV?
4. Are treatment modalities used by North Dakota CRNAs’ similar to the Mott 
Children’s Hospital algorithms?
The population of this research project consisted of all currently licensed North 
Dakota CRNAs. Of the 150 surveys sent, 145 were delivered, and five surveys were 
returned to the sender due to change of address; of the 145 that were delivered, 117 were 
returned to the researcher, which produced an 81% return rate. Two participants were 
excluded secondary to failure to complete the survey entirely, and four others were 
excluded due to return of their surveys after data were analyzed. Therefore, the total 
number of surveys analyzed was 112.
Collected data were analyzed using chi-square; a significance level of p -  .05 was 
used for this study. Demographics of this study included 62 female respondents, and 50 
male respondents. Descriptive statistics were used to answer the research questions 
presented in this paper. The gender, frequency-of-working in North Dakota, and 
frequency of providing pediatric anesthesia are shown in Table 1. Frequency-of-working 
was broken into three categories of part-time, full-time and locum, the categories being
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rare (less than one patient per week), occasionally (at least one patient per week), and 
frequently (more than one patient per week).










Rarely (cone pt/wk) 24 21.4
Occasionally (one pt/wk) 48 42.9
Frequently (>one pt/wk) 40 35.7
Number of months that the CRNA’s had worked as a locum in North Dakota 
varied from one month to five months each year. The mean years worked of all the 
CRNAs that responded to the survey were 14 years, ranging from one year to 37 years.
The first research question, what impact does age, gender and years of experience 
of North Dakota CRNAs have on treatment of postoperative nausea and vomiting in the 
pediatric population, was addressed using the chi-square analysis. Where sample data of 
nominal scaling are from one population, the chi-square test-of-independence is a used to 
test a null hypothesis that the attributes of the elements of a given population are not 
related (Mann, 2004). Gender of North Dakota CRNAs was obviously separated into
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male and female categories. The difference in gender between male and female CRN As 
was not significant (chi-square test = 9.449, df = 4, p = 0.5).
Years of experience was also studied to identify if number of years practicing as a 
CRN A affected one’s choice to treat pediatric PONV. The difference in years of 
experience was divided into four categories: new CRNA (five years of experiences, or 
less); intermediate CRNA (six to nine years of experience); advanced (ten to fifteen 
years); and expert (greater than 15 years experience). Chi-square was run on this data 
and the results indicated that CRNAs who treated PONV and years of experience are not 
related.
The research question, “Were treatment modalities used by North Dakota CRNAs 
similar to the Mott Children’s Hospital algorithms?” (Appendix A and B), was analyzed. 
The Motts Children's Hospital algorithms were created after doing a thorough literature 
review. These algorithms were created for the management of pediatric patients with 
both low-risk PONV (Appendix A), and high-risk PONV (Appendix B). The Mott 
Children’s Hospital algorithms indicate that not all children require treatment for PONV, 
and both the low- and high-risk patients must be identified.
The North Dakota CRNAs were questioned on the frequency of PONV in the 
pediatric population that they serve. The incidence of pediatric PONV was divided into 
rarely (less than 25 % of the patients), occasionally (approximately 50% of the patients), 
and frequently (greater than 75% of the patients). Table 2 represents those results.
Giving medications prior to the incidence of having nausea and vomiting is 
termed prophylactic treatment. North Dakota CRNAs reported prophylactically treating
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their pediatric patient with antiemetics 75% of the time. The results of the survey 
question are listed in Table 3.
Table 2. Frequency of Pediatric PONY in Treated Population.
Incidence of PONY n %
Rare (<25% of pts) 74 66.1
Occasionally (50% of pts) 14 12.5
Frequently (>75% of pts) 3 2.7
Unsure 21 18.8
Table 3. Prophylactic Treatment of Pediatric Patients for PONY.
Prophylactic Treatment N %
Rarely (<25%) 17 15.2
Occasionally (50%) 20 17.9
Frequently (>75%) 75 67.0
Not clearly defined by the collected data, the analysis of the second research 
question, “What are the variations in therapeutic modalities used by CRNAs in North 
Dakota in treatment of pediatric PONY?” was addressed by the survey question 
regarding treatment techniques. The survey requested that the CRNAs check all of the 
techniques used when they were concerned with PONY in the pediatric patient. The five 
treatment options listed were: total intravenous anesthesia, extra intravenous fluids,
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ketorolac, rather than opioids, premedication with anxiolytics, and high concentration 
oxygen. All of the options are from the Motts Children’s Hospital high risk for PONV 
algorithm (Appendix B) The data were categorized into the total number of responses 
the CRN A chose from the list provided on a scale from one to five. Table 4 shows these
results of the treatment options.
Table 4. Techniques Used for Treatment of Pediatric PONV.






Of the 112 respondents, only six appropriately responded to all choices as options 
they would use to treat pediatric PONV.
The third research question, “What are the considerations that affect North Dakota 
CRNAs’ decision to treat pediatric PONV?” was addressed by the survey question of 
how the anesthetic plan is derived and limitations of antiemetic availability. The 
anesthetic plan to treat pediatric postoperative nausea and vomiting was divided into 
three separate categories: independently, in collaboration with the anesthesiologist, or in 
collaboration with the surgeon. Despite the request to answer the survey questions with 
one response, six survey respondents answered the question with more than one answer.
33
Consequently, these six surveys were not compiled into the data. The anesthetic plan to 
treat PONV is listed in Table 5.
Many factors play a role in the limitation of CRNA for treatment options. The 
limitations were divided into four different categories: hospital limitation of drug 
availability, time restraints to give adequate preoperative antiemetics, MD 
preference/limitation, and having no limitation of antiemetic treatment of pediatric 
PONV. Table 6 display those results.
Table 5. Anesthetic Plan to Treat Pediatric PONV.
Plan N %
Independently 66 58.9
Collab.with Anesthesiologist 33 29.4
Collab. with Surgeon 7 6.3
Table 6. Limitation of CRNAs Treatment Options for Treatment for Pediatric PONV.
Limitation N %
Hospital Limitation 41 36.6
Time Restraints 2 1.8
MD preference/limitation 16 14.3
No limitation 53 47.3
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In addition, in answering the research question, “Are treatment modalities used by 
North Dakota CRNAs’ similar to the Mott Children’s Hospital algorithms?” the 
following survey question was asked, according to high-risk surgeries. The CRNAs were 
asked how they prophylactically treat pediatric patients for PONV in accordance to both 
high- and low-risk surgeries. The surgeries chosen are surgeries that are commonly 
performed in North Dakota hospitals. The high-risk surgeries included tonsillectomy, 
middle ear, and strabismus. The low-risk surgeries include abdominal, inguinal hernia, 
and orthopedic. Respondents were asked how frequently they medicated for each 
surgery, according to the following percentage classifications: rarely (<25%), 
occasionally (50%), often (>75), or not at all. Table 7 shows the responses of treatment. 
Table 7. Surgeries that ND CRNAs Prophylactically Treat for PONV.
Surgeries Frequency
Rare Occas. (50%) Often (>75%) Never
Tonsillectomy 5 13 90 4
Middle Ear 10 7 84 11
Strabismus 7 12 78 15
Abdominal 12 24 63 13
Inguinal Hernia 15 26 59 12
Orthopedic 17 30 50 15
Other 8 3 7 94
Additional information collected from the survey is listed in Tables 8, 9, and 10. 
Tables 8 - 1 0  indicate medications that were used for prophylactic, intraoperative, and
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rescue therapy for pediatric PONV. In table 8, the data was summarized to relate the 
number of times they prophylactically treated their pediatric patients with each of the 
following drugs. The categories for each column for the next three tables were all broken 
down into either rare (less than 25% of the patients), occasionally (50% of the patients), 
often (greater than 75% of the patients), or never.
Table 8. ND CRNAs Prophylactic Treatment of PONV.
Frequency
Medication Rare (<25%) Occas. (50%) Often (>75%) Never
Dexamethasone 12 29 63 8
Ondansetron 11 19 54 28
Droperidol 37 9 9 57
Granisetron 23 12 27 50
Metoclopramide 32 19 7 54
Scopolamine 34 4 2 72
Other 8 1 14 89
Table 9 reports how effective the anesthetist found each of the drugs they used on 
pediatric PONV to be. This information is subjective and reports the perception of the 
anesthetists’ feelings about each of the drugs.
In Table 10, the results of the information of what drugs CRNAs used to treat for 
rescue pediatric PONV. In the write in portion of this category, anesthetists frequently 
provided information stating they did not frequently treat rescue PONV. The 
anesthesiologist treated rescue PONV.
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Table 9. ND CRNAs Found These Medications to be Effective for Pediatric PONY.
Frequency
Medication Rare (<25%) Occas. (50%) Often (>75%) Never
Dexamethasone 4 23 70 15
Ondansetron 5 8 73 26
Droperidol 12 9 26 65
Granisetron 14 11 27 60
Metoclopramide 12 24 10 66
Scopolamine 16 9 4 83
Other 7 2 10 93
Table 10. ND CRNAs Use These Medication for Rescue Pediatric PONY.
Frequency
Medication Rare (25%) Occas. (50%) Often (>75%) Never
Dexamethasone 21 9 22 60
Ondansetron 10 16 42 44
Droperidol 22 12 16 62
Granisetron 17 14 7 74
Scopolamine 0 0 0 0
Other 7 4 8 93
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CHAPTER V
SUMMARY, DISCUSSION AND RECOMMENDATIONS
The purpose of this study was to evaluate North Dakota CRNAs treatment of 
pediatric postoperative nausea and vomiting. This chapter will summarize the findings of 
the study, discuss further research necessary, and provide recommendations for research, 
policy, education, and practice of pediatric PONV. A conclusion of that analysis is 
presented in this chapter.
Summary
Postoperative pediatric nausea and vomiting continues to be a significant problem 
for anesthesia providers. Pediatric postoperative nausea and vomiting can also cause 
other, significant complications with morbidity and mortality; consequently, anesthesia 
providers are constantly striving to prevent and treat these complications. Many studies 
have been conducted on antiemetics, which identified factors such as history of previous 
postoperative nausea and vomiting or motion sickness, anesthetic technique, type of 
surgical procedure, and length of surgery should be considered during the analysis of the 
risk of PONV in pediatrics.
A rational plan for each child in the low- and high-risk categories should be 
anticipated. With a rational approach to the management of PONV, it should be possible 




It is important that anesthesia providers remain current with their understanding 
of new, antiemetic drugs; accordingly, they must be aware of the drugs that are affective 
for rescue versus the drugs that are affective for prophylactic treatment. The results of 
this study will be presented at the spring, 2005 North Dakota anesthesia conference.
Recommendation of Practice
Since pediatric, postoperative nausea and vomiting continues to be a major 
concern in the anesthesia field, the practice of treating postoperative nausea and vomiting 
in the pediatric population must be continually evaluated until the problem is minimized, 
or alleviated altogether. As CRN As gain insight on how they can improve their care, 
their practice will continually develop. Sharing the results of studies in such areas as in 
hospital staff meetings and at annual anesthesia conferences, will help CRNAs make 
educated choices when it comes to treating pediatric postoperative nausea and vomiting.
In several North Dakota facilities, the survey identified that the anesthesiologist 
performed both the preoperative and postoperative visits with the pediatric patients, and 
the CRNAs provided the anesthesia to the patients. CRNAs of North Dakota reported 
that sufficient follow-up communication between the anesthesiologist and the anesthetist 
was not consistently occurring to identify patients that experienced PONV. This led the 
researcher to recommend a paradigm of better, postoperative follow-up communication 
by the CRNA, or better communication between the disciplines was in order.
Recommendation of Policy
It was found through an extensive literature review, that following an algorithm to 
identify pediatric patients at low or high risk for postoperative nausea and vomiting
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would create a more unified approach to treatment. Identifying risks for PONV is the 
initial part of treatment. Mott Children’s Hospital algorithms list causative factors that 
place pediatric patients at risk. Recommendation is made to implement a policy for 
practice of treating pediatric PONV, using research based algorithms, such as ones 
created by Mott Children’s Hospital.
Recommendation of Research
Recommendation for future research might include surveying the pediatric patient 
population -  both postoperative and upon discharge -  from the hospital. Frequently, 
pediatric patients may have PONV after discharge from a same-day procedure, and the 
anesthesia provider will be unaware of the event.
Also of interest would be to survey anesthesiologists, who frequently perform 
postoperative visits. The survey should include questions to identify how thoroughly 
they evaluate postoperative nausea and vomiting, and how the follow-up information is 
disseminated back to the CRNAs who provided the anesthesia to the pediatric patient.
To evaluate if anesthesia providers are treating postoperative nausea and vomiting 
differently in other regions of the country, this study should be administered to different 
regions of the United States. Respondents were not asked the question about the 
background of their education. The same “school-of-thought” may be taught to 
practicing CRNAs in regards to treating pediatric PONV, depending on were they 
received their graduate education. Even though the data obtained from this study may, or 
may not be generalized nationally, the survey questions confirmed this by the fact that all 
North Dakota CRNAs used at least one of the treatment techniques suggested by Mott 
Children’s Hospital algorithms for treatment of suspected (high-risk) postoperative
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nausea and vomiting in the pediatric patient. In addition, North Dakota CRNAs reported 
that 66% of the time, their pediatric patient rarely had PONV.
Upon completion of the study, it was found that North Dakota anesthetists are not 
over-treating, under-treating, but are appropriately treating pediatric PONV, as compared 
to the evidence-based, Mott Children’s Hospital algorithms. The Mott Children’s 
Hospital algorithms for low-risk and high-risk PONV algorithms were created after doing 
a thorough literature review for the management of patients with low (Appendix A) and 
high (Appendix B) risk for PONV. Over-treating of pediatric PONV can create 
unnecessary increased cost, drug interactions, and side effects to the patients. Under­
treatment may cause extended hospital stay, increased hospital charges, and an 
unpleasant experience for the pediatric patient. The data obtained indicated that there 
was no significant difference in the treatment modalities of North Dakota CRNAs from 
the Mott Children’s Hospital Algorithms.
Since pediatric postoperative vomiting continues to the leading cause of 
morbidity after surgery, it must continue to be a serious consideration in the practice of 
anesthesia. The anesthetist must be able to identify pediatric patients at low or high risk 
for PONV and understand how to best treat each individual patient. The North Dakota 
CRNAs all had made some type of effort in regards to treatment of pediatric PONV but 
continued improvement should always be the goal.
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APENDIX A
MOTT CHILDREN'S HOSPITAL LOW-RISK ALGORITHM
P RE OPERATIVE
LOW RISK FOR PONV
Fig 1. Prevention and treatment of pediatric PO N V  low-risk algorithm. Traditional antiemetics include the following: droperidol 
10 to 20 /xg/kg, intravenously (IV) (max 0.625 mg); metoclopramide 0.15 mg/kg, IV  (max 10 mg); trim ethobenzam ide 100 mg, per 
rectum (PR) (children less than 14 kg) or 100 to 200 mg, PR (children more than 14 kg); promethazine 0.25 to 0.5 mg/kg, IV  or PR 
(max 25 mg); prochlorperazine 0.13 m g/kg intram uscular (IM) (max 10 mg; not in children less than 20 lbs or less than 2 years of 
age). Reprinted with perm ission from C.S. M ott Children 's Hospital, Ann  Arbor, M l
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APPENDIX B
MOTT CHILDREN’S HOSPITAL HIGH-RISK ALGORITHM
Fig 2. Prevention and treatment of pediatric PONV high-risk algorithm. Traditional antiemetics include the following: droperidol 
10 to 20 pg/kg, intravenously (IV) (max 0.625 mg); metoclopramide 0.15 mg/kg, IV (max 10 mg); trimethobenzamide 100 mg, per 
rectum (PR) (children less than 14 kg) or 100 to 200 mg, PR (children more than 14 kg); promethazine 0.25 to 0.5 mg/kg, IV or PR 
(max 25 mg); prochlorperazine 0.13 mg/kg intramuscular (IM) (max 10 mg; not in children less than 20 lbs or less than 2 years of 






323 4th St NE 
Sidney, MT 59270
Dear North Dakota CRNA’s,
My name is Mary Bidegaray, and I am a graduate student at the University of 
North Dakota currently completing my Master of Science Degree in Nursing with a 
specialization in anesthesia. As part of my thesis requirements, I am engaged in a study 
concerning the treatment of postoperative nausea and vomiting (PONV) in the pediatric 
population.
Your name was selected from a list of active CRNAs in the state of North Dakota. 
I hope that you will be able to complete this important survey. This study will take 
approximately 5 minutes of your time to complete. I hope you find the questions 
interesting. Please complete the questions in the order in which they are presented. You 
have the right to skip any questions you do not wish to answer, and you may stop 
completing the questionnaire at any time you wish without penalty. I hope, however, that 
you will complete the survey in its entirety. There are no right or wrong answers. Please 
be as truthful as possible. Your answers are completely confidential. Please do not put 
your name on the questionnaire and no one will know how you answered the items. The 
returned questionnaires will be locked and stored in the nursing building on the UND 
campus, then destroyed after a period of no less than three years. Only the researcher, 
advisory, and IRB auditor will have access to the data. The results will be summarized in 
my final thesis paper. Your consent to participate will be assumed by your completion 
and return of the enclosed questionnaire.
If you have any questions feel free to contact me at (303)905-0935 or my 
chairperson, Dr. Julie Anderson at (701)777-4541. If you have any other questions, 
please contact the Office of Research and Program Development at (701 )777-4279. In 
addition, if you are interested in an abstract of my results, feel free to contact me at the 
above address or the below via email address.







Survey for North Dakota CRNAs




I have worked as a CRNA for 
______ years




If locum, please give number of months per year working in North Dakota_________________________
I provide anesthesia to pediatric patients
______ Rarely (less than one patient per week)
______ Occasionally (at least one patient per week)
______ Frequently (more than one patient per week)
I make my anesthetic plan to treat pediatric PONV 
______Independently
______ In collaboration with the anesthesiologist
______ In collaboration with the surgeon
I am limited on which antiemetics I use for my pediatric patients by
______ Hospital limitation of drug availability
______ Time restraints to give adequate preoperative antiemetics
______ MD preference/limitation
______I have no limitation of antiemetics I use for pediatric PONV




The incidence of nausea and vomiting in the pediatric population I service is
______ Rare (less than 25% of the patients)
______ Occasionally (approximately 50% of the patients)
______Frequently (more than 75% of the patients)
______Unsure
I use the following techniques when I am concerned with PONV in the pediatric patient (Please check all 
that apply)
______Total intravenous anesthesia
______ Extra IV hydration
______ Ketorolac rather than opioids
______ Premedication with anxiolytic (midazolam)
______ High concentration oxygen
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Please indicate for which type of pediatric surgical procedure(s) that you currently treat prophylactically for 
PONV:
Surgeries Frequency
Rare (<25%) Occasional (50%) Often (>75%)
Tonsillectomy ____________ ______________ ___________
Middle ear ____________ ______________ ___________
Strabismus ____________ ______________ ___________
Abdominal ____________ ______________ ___________
Inguinal hernia ____________ ______________ ___________
Orthopedic ____________ ______________ ___________
Other ____________ ______________ ___________
Please explain:_______________________________________________________
Medication(s) I would choose for prophylactic treating pediatric PONV:
Medication Frequency
Rare (<25%) Occasional (50%) Often (>75%)
Dexamethasone (steroid) ____________  ______________  ____________
Ondansetron (5HT-3 blocker) ____________  ______________  ____________
Droperidol (Dopa receptor) ____________  ______________  ____________
Granisetron (5Ht-3 blocker) ____________  ______________  ____________
Metoclopramide (prokinetic) ____________ ____________________ __________________
Scopolamine (anticholinergic) ____________  ______________  ____________
Other ____________  ______________  ____________
Please explain:__________________________________________________________________
I find that these medication(s) are effective for pediatric PONV:
Medication Effective
Rare (<25%) Occasional (50%) Often (>75%)
Dexamethasone ___________ ______________ ___________
Ondansetron ___________ ______________ ___________
Droperidol _____________________________________________
Granisetron ___________ ______________ ___________
M e t o c l o p r a m i d e ______________________________ ___________
Scopolamine ___________ ______________ ___________
Other ___________ ______________ ___________
Please explain:_________________________________________________________
I use these medications for pediatric PONV rescue therapy:
Medication Frequency
Rare (<25%) Occasional (50%) Often (>75%)
Dexamethasone ___________ ______________ ___________
Ondansetron ___________ ______________ ___________
Droperidol ___________ ______________ ___________
Granisetron ____________________________________________
Metoclopramide ___________ ______________ ___________
Scopolamine ___________ ______________ ___________




Aouad, M., Siddik, S., Rizk, L., Zaytoun, G., & Baraka, A. (2001). The effect of
dexamethasone on postoperative vomiting after tonsillectomy. Anesthesia and 
Analgesia, 92: 636-670.
Carroll, N., Miederhoff, P., Cox, F., & Hirsch, J. (1999). Costs incurred by outpatient 
surgical centers in managing postoperative nausea and vomiting. Journal of 
Clinical Anesthesia, 6: 536-543.
Cieslak, G., Watcha M., Phillips M., & Pennant J. (1996). The dose-response relation 
and cost-effectiveness of granisetron for the prophylaxis of pediatric 
postoperative emesis. Anesthesiology, 11;85(5): 1076-1085.
Cleveland Clinic Information Center. About nausea and vomiting.
http://clevelandclinic.org/health/health-info/docs. Retrieved March 22, 2004.
Chhibber, A., Lustik, S., Thakur, R., Francisco, D., & Fickling, K. (1999). Effects of
anticholinergics on postoperative vomiting, recovery, and hospital stay in children 
undergoing tonsillectomy with or without adenoidectomy. Anesthesiology, 90: 
697-700.
Davis, P., McGowan, F., Landsman, I., Maloney, K., & Hoffmann, P. (1995). Effect of 
antiemetic therapy on recovery and hospital discharge time. Anesthesiology,
83(5):956-960.
53
Drake, R., Anderson, B., Persson, M., & Thompson, J. (2001). Impact of an antiemetic 
protocol on postoperative nausea and vomiting in children.
Paediatric Anaesthesia, 11: 85-91.
Fujii, Y., Tanaka, H., & Toyooka, H. (1998). A granisetron-droperidol combination 
prevents postoperative vomiting in children. Anesthesia and Analgesia, 87: 
761-765.
Fujii, Y., Tanaka, H., & Toyooka, H. (1999). Preoperative oral antiemetics for reducing 
postoperative vomiting after tonsillectomy in children: granisetron versus 
perphenazine. Anesthesia and Analgesia, 88: 1298-1301.
Hansen, M. (1998). Pathophysiology foundations of disease and clinical interventions 
(1st ed.) Philadelphia, PA: W. B. Saunders Company.
Gan, T. J., Meyer, T., Apfel, C., Chung, F., Davis, P., Eubanks, S., Kovac, A., Philip, B., 
Sessler, D., Temo, J., Tramer, M., & Watcha, M. (2003). Consensus guidelines 
for managing postoperative nausea and vomiting. Anesthesia and Analgesia, 97: 
62-71.
Kearney, J., Mack, C., & Entwistle, M. (1998). Withholding oral fluids from children
undergoing day surgery reduces vomiting. Paediatric Anaesthesia, 6: 1046-1060.
Kovac, A. L. (2000). Prevention and treatment of postoperative nausea and vomiting.
Drug, 59: 213-243.
Mann, P. S. (2004). Introductory Statistics (5th ed.) Hoboken, NJ: John Wiley & Sons, 
Inc.
Medline Plus. Ondansetron-Systemic, www.nlm.nih.gov/medlineplus/ 
druginfo/uspdi/202424.html. Retrieved March 12,2004.
54
Munro, H. (2000). Postoperative nausea and vomiting in children. Journal of 
Peri Anesthesia Nursing, 75(6): 401-407.
Olutoye, O., Jantzen, E., Alexis, R., Rajechert, D., Shreiner, M., & Watcha, M. (2003).
A comparison of the costs and efficacy of ondansetron and dolasetron in the 
prophylaxis of postoperative vomiting in pediatric patients undergoing 
ambulatory surgery. Anesthesia and Analgesia, 97: 390-397.
Pandit, U., Malviya, S., & Lewis, I. (1995). Vomiting after outpatient tonsillectomy and 
adenoidectomy in children: the role of nitrous oxide. Anesthesia and Analgesia, 
80: 230-233.
Patel, R., Davis, P., Orr, R., Ferrari, L., Rimar, S., Hannallah, R., Cohen, I., Colingo, K., 
Donlon, J., Haberkern, C., Mcgowen, F., Prillaman, B., Parasuraman, T., &
Creed, M. (1997). Single-dose ondansetron prevents postoperative vomiting in 
pediatric outpatients. Anesthesia and Analgesia, 85: 538-545.
Rose, J., & Watcha, M. (1999). Postoperative nausea and vomiting in paediatric patients. 
British Journal of Anaesthesia 83(1): 104-117.
Rusy, L., Hoffman, G., & Weisman, S. (2002). Electroacupuncture prophylaxis of
postoperative nausea and vomiting following pediatric tonsillectomy or without 
adenoidectomy. Anesthesiology, 96: 300-305.
Sadhasivam, S., Shende, D., & Madan, R. (2000). Prophylactic ondansetron in
prevention of postoperative nausea and vomiting following pediatric strabismus 
surgery. Anesthesiology, 92: 1035-42.
55
Scuderi, P., James, R., Harris, L., & Mims, G. (1999). Antiemetic prophylaxis does not 
improve outcomes after outpatient surgery when compared to symptomatic 
treatment. Anesthesiology, 90: 360-71.
Splinter, W., & Roberts, D. (1997). Prophylaxis for vomiting by children after
tonsillectomy: dexamethasone versus perphenazine. Anesthesia and Analgesia, 
85: 534-537.
Thompson, H. (1999). The management of post-operative nausea and vomiting.
Journal of Advanced Nursing, 29(5): 1130-6.
Wang S., & Kain, Z. (2000). Preoperative anxiety and postoperative nausea and
vomiting in children: is there an association? Anesthesia and Analgesia, 90: 
571-575.
Watcha, M. (2004). Special Report: Antiemetic Drugs in the Prevention and treatment 
of postoperative vomiting in children. Anesthesiology News, April 2004.
Watcha, M., Bras, P., Cieslak, G., & Pennant, J. (1995). The dose-response relationship 
of ondansetron in preventing postoperative emesis in pediatric patients 
undergoing ambulatory surgery. Anesthesiology, 82(2):47-52.
White P. F. (2002). Droperidol: a cost-effective antiemetic for over thirty years. 
Anesthesia and Analgesia, 95: 789-790.
56
